Waystar (NASDAQ:WAY) Downgraded to Hold Rating by Wall Street Zen

Waystar (NASDAQ:WAY) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Sunday.

Several other equities research analysts have also issued reports on the company. Leerink Partners assumed coverage on Waystar in a report on Monday, February 2nd. They set an “outperform” rating and a $43.00 price target for the company. Bank of America reduced their price target on Waystar from $45.00 to $38.00 and set a “buy” rating for the company in a report on Friday, April 10th. Canaccord Genuity Group reduced their price target on Waystar from $54.00 to $30.00 and set a “buy” rating for the company in a report on Wednesday, February 18th. Weiss Ratings upgraded Waystar from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Finally, JPMorgan Chase & Co. reduced their price target on Waystar from $40.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. Four research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $35.62.

Waystar Price Performance

NASDAQ:WAY opened at $19.57 on Friday. The firm has a market cap of $3.75 billion, a P/E ratio of 29.21, a PEG ratio of 0.77 and a beta of 0.21. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.37. Waystar has a 52-week low of $17.89 and a 52-week high of $41.49. The business’s 50-day moving average price is $22.87 and its 200 day moving average price is $27.92.

Waystar (NASDAQ:WAY) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.03. The business had revenue of $313.87 million during the quarter, compared to analyst estimates of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The firm’s revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. As a group, sell-side analysts predict that Waystar will post 1.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in shares of Waystar by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 12,330,872 shares of the company’s stock valued at $403,836,000 after acquiring an additional 41,062 shares in the last quarter. Advent International L.P. bought a new position in shares of Waystar in the 4th quarter valued at approximately $362,212,000. William Blair Investment Management LLC grew its holdings in Waystar by 0.4% in the 4th quarter. William Blair Investment Management LLC now owns 5,282,220 shares of the company’s stock valued at $172,993,000 after buying an additional 19,033 shares during the last quarter. State Street Corp grew its holdings in Waystar by 4.0% in the 4th quarter. State Street Corp now owns 4,134,052 shares of the company’s stock valued at $135,390,000 after buying an additional 159,183 shares during the last quarter. Finally, Alliancebernstein L.P. increased its position in Waystar by 4.5% in the 3rd quarter. Alliancebernstein L.P. now owns 3,415,442 shares of the company’s stock worth $129,514,000 after buying an additional 146,510 shares during the period.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.